Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Boyer

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Retina (Philadelphia, Pa.)|November 16, 2023
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery SystemDavid Boyer, Allen Hu, David Warrow, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 16, 2024
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema - How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck RetinaAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Translational Neurodegeneration|February 1, 2022
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's diseaseShirley Yin-Yu Pang, Rachel Cheuk Nam Lo, Philip Wing-Lok Ho, et al.
Retina (Philadelphia, Pa.)|March 6, 2026
Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis)Glenn J Jaffe, David Boyer, Allen Hu, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonistsPaul S Humphries, John W Benbow, Paul D Bonin, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 21, 2007
Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutationMan-Cheuk Ng, Jenny Ting Ho, Shu-Leong Ho, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
Lancet (London, England)|October 21, 2023
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trialsJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Immunotherapy|January 17, 2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studiesJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Expert Opinion on Biological Therapy|February 2, 2023
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey)Ashish Sharma, Frank G Holz, Carl D Regillo, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Retina (Philadelphia, Pa.)|November 16, 2023
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery SystemDavid Boyer, Allen Hu, David Warrow, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 16, 2024
RWC Update: Different Surgical Techniques for Macular Hole Associated With Retinal Detachment; Diabetic Macular Edema - How Do You Treat Patients With Good Visual Acuity?; Benign Familial Fleck RetinaAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Translational Neurodegeneration|February 1, 2022
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's diseaseShirley Yin-Yu Pang, Rachel Cheuk Nam Lo, Philip Wing-Lok Ho, et al.
Retina (Philadelphia, Pa.)|March 6, 2026
Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis)Glenn J Jaffe, David Boyer, Allen Hu, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonistsPaul S Humphries, John W Benbow, Paul D Bonin, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 21, 2007
Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutationMan-Cheuk Ng, Jenny Ting Ho, Shu-Leong Ho, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
Lancet (London, England)|October 21, 2023
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trialsJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Immunotherapy|January 17, 2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studiesJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Expert Opinion on Biological Therapy|February 2, 2023
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey)Ashish Sharma, Frank G Holz, Carl D Regillo, et al.
Pageof 8